Cefuroxime resistance in non-beta-lactamase Haemophilus influenzae is linked to mutations in ftsI

K Straker1, M Wootton, A M Simm

  • 1Bristol Centre of Antimicrobial Research and Evaluation (BCARE), Department of Pathology and Microbiology, University of Bristol, Bristol BS8 1TD, UK.

Insights

Cefuroxime resistance in Haemophilus influenzae type b is linked to specific mutations in the FtsI penicillin-binding protein (PBP) gene. This study identifies the S357N substitution as a key factor contributing to cefuroxime resistance.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Genetics

Background:

  • Haemophilus influenzae type b is a significant pathogen.
  • Antibiotic resistance, particularly to beta-lactams like cefuroxime, is a growing concern.
  • Penicillin-binding proteins (PBPs) are crucial targets for beta-lactam antibiotics.

Purpose of the Study:

  • To investigate the molecular basis of cefuroxime resistance (CXM(R)) in Haemophilus influenzae type b.
  • To identify specific mutations in penicillin-binding protein (PBP) genes associated with CXM(R).

Main Methods:

  • Molecular characterization of PBP genes (dacA, dacB, ftsI) from cefuroxime-resistant isolates.
  • Genetic transformation experiments to confirm the role of identified mutations.
  • Structural analysis of PBP FtsI to understand the impact of mutations.

Main Results:

  • No significant mutations were found in dacA or dacB associated with CXM(R).
  • A specific amino acid substitution, S357N, in the FtsI gene product was identified as a potential cause of CXM(R).
  • Transformants also showed resistance linked to FtsI substitutions (V511A and R517H).

Conclusions:

  • The FtsI gene is implicated in cefuroxime resistance in Haemophilus influenzae type b.
  • The S357N substitution in FtsI is a key mutation conferring cefuroxime resistance.
  • This study provides the first analysis of PBP roles in CXM(R) for H. influenzae.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Conjugation01:19

Conjugation

Conjugation is a form of horizontal gene transfer that primarily occurs in bacteria and some archaea, promoting genetic diversity and adaptation. Bacteria can acquire resistance genes through conjugative plasmids, allowing them to survive antibiotic treatments that would otherwise be lethal. This process involves direct contact between cells through specialized structures such as the sex pilus and is mediated by conjugative plasmids, including the F (fertility) factor.Conjugation requires...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...